(Q36479860)

14 August 2017

1 reference

title

Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline (English)

1 reference

14 August 2017

main subject

cerebrovascular disease

1 reference

Francesco Panza

1

0 references

author name string

Vincenzo Solfrizzi

2

1 reference

14 August 2017

Anna M Colacicco

3

1 reference

14 August 2017

Alessia D'Introno

4

1 reference

14 August 2017

Cristiano Capurso

5

1 reference

14 August 2017

Rossella Palasciano

6

1 reference

14 August 2017

Orlando Todarello

7

1 reference

14 August 2017

Sabrina Capurso

8

1 reference

14 August 2017

Vincenza Pellicani

9

1 reference

14 August 2017

Antonio Capurso

10

1 reference

14 August 2017

publication date

1 April 2006

1 reference

Aging Clinical and Experimental Research

14 August 2017

published in

1 reference

14 August 2017

volume

18

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

144-148

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03327430

14 August 2017

exact match

0 references

cites work

Stroke prevention, blood cholesterol, and statins

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Vascular risk and genetics of sporadic late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Incidence and Risk Factors of Dementia in a Defined Elderly Japanese Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Factors associated with vascular dementia in an elderly community population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Statins in the prevention and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Poststroke dementia: incidence and relationship to prestroke cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Silent brain infarcts and the risk of dementia and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03327430

21 January 2018

Identifiers

DOI

10.1007/BF03327430

1 reference

14 August 2017

1 reference